Back to UBS Group AG UBS Group AG

CGONCGON
10 quarters

Position history for UBS Group AGUBS Group AG's holdings in CG ONCOLOGY INC

UBS Group AG holds 977,695 shares of CGON (CG ONCOLOGY INC), worth $69.5M as of 2026-Q2. The position was decreased (-25.5% shares). CGON represents 0.0% of UBS Group AG's portfolio.

Current Value

$69.5M

Current Shares

977,695

Total Value Change

+$68.4M

Total Shares Change

+954,372

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
977,695
-25.5%
$69.5M0.0%$71.05
0
2026-Q1
Decreased
1.3M
-31.8%
$88.8M0.0%$60.55
0
2025-Q4
Decreased
1.9M
-9.5%
$79.9M0.0%$40.17
0
2025-Q3
Decreased
2.1M
-4.6%
$85.6M0.0%$39.08
0
2025-Q2
Increased
2.2M
+30.8%
$58M0.0%$25.95
37
2025-Q1
Increased
1.7M
+68.1%
$41.7M0.0%$26.42
43
2024-Q4
Increased
1M
+1071.7%
$29.1M0.0%$28.50
46
2024-Q3
Increased
86,534
+10.8%
$3.3M0.0%$37.87
29
2024-Q2
Increased
78,080
+234.8%
$2.5M0.0%$31.57
42
2024-Q1
New
23,323
-
$1M0.0%$43.90
35

Other major holders of CGON: RTW INVESTMENTS, LP, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used